| Year |
Citation |
Score |
| 2024 |
Yadav-Samudrala BJ, Ravula HP, Barmada KM, Dodson H, Poklis JL, Ignatowska-Jankowska BM, Lichtman AH, Reissner KJ, Fitting S. Acute Effects of Monoacylglycerol Lipase Inhibitor ABX1431 on Neuronal Hyperexcitability, Nociception, Locomotion, and the Endocannabinoid System in HIV-1 Tat Male Mice. Cannabis and Cannabinoid Research. PMID 38394322 DOI: 10.1089/can.2023.0247 |
0.355 |
|
| 2023 |
Yadav-Samudrala BJ, Gorman BL, Dodson H, Ramineni S, Wallace ED, Peace MR, Poklis JL, Jiang W, Fitting S. Effects of acute Δ-tetrahydrocannabinol on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice. Brain Research. 1822: 148638. PMID 37858856 DOI: 10.1016/j.brainres.2023.148638 |
0.815 |
|
| 2023 |
Cheng D, Luo Z, Fitting S, Stoops W, Heath SL, Ndhlovu LC, Jiang W. The link between chronic cocaine use, B cell perturbations, and blunted immune recovery in HIV-infected individuals on suppressive ART. Neuroimmune Pharmacology and Therapeutics. 2: 71-79. PMID 37027536 DOI: 10.1515/nipt-2022-0019 |
0.367 |
|
| 2022 |
Xu C, Yadav-Samudrala BJ, Xu C, Nath B, Mistry T, Jiang W, Niphakis MJ, Cravatt BF, Mukhopadhyay S, Lichtman AH, Ignatowska-Jankowska BM, Fitting S. Inhibitory Neurotransmission Is Sex-Dependently Affected by Tat Expression in Transgenic Mice and Suppressed by the Fatty Acid Amide Hydrolase Enzyme Inhibitor PF3845 via Cannabinoid Type-1 Receptor Mechanisms. Cells. 11. PMID 35269478 DOI: 10.3390/cells11050857 |
0.4 |
|
| 2021 |
League AF, Gorman BL, Hermes DJ, Johnson CT, Jacobs IR, Yadav-Samudrala BJ, Poklis JL, Niphakis MJ, Cravatt BF, Lichtman AH, Ignatowska-Jankowska BM, Fitting S. Monoacylglycerol Lipase Inhibitor MJN110 Reduces Neuronal Hyperexcitability, Restores Dendritic Arborization Complexity, and Regulates Reward-Related Behavior in Presence of HIV-1 Tat. Frontiers in Neurology. 12: 651272. PMID 34484091 DOI: 10.3389/fneur.2021.651272 |
0.805 |
|
| 2021 |
Hermes DJ, Yadav-Samudrala BJ, Xu C, Paniccia JE, Meeker RB, Armstrong ML, Reisdorph N, Cravatt BF, Mackie K, Lichtman AH, Ignatowska-Jankowska BM, Lysle DT, Fitting S. GPR18 drives FAAH inhibition-induced neuroprotection against HIV-1 Tat-induced neurodegeneration. Experimental Neurology. 113699. PMID 33736974 DOI: 10.1016/j.expneurol.2021.113699 |
0.462 |
|
| 2021 |
Yadav-Samudrala BJ, Fitting S. Mini-review: The therapeutic role of cannabinoids in neuroHIV. Neuroscience Letters. 135717. PMID 33587986 DOI: 10.1016/j.neulet.2021.135717 |
0.451 |
|
| 2020 |
Hermes DJ, Jacobs IR, Key MC, League AF, Yadav-Samudrala BJ, Xu C, McLane VD, Nass SR, Jiang W, Meeker RB, Ignatowska-Jankowska BM, Lichtman AH, Li Z, Wu Z, Yuan H, ... ... Fitting S, et al. Escalating morphine dosing in HIV-1 Tat transgenic mice with sustained Tat exposure reveals an allostatic shift in neuroinflammatory regulation accompanied by increased neuroprotective non-endocannabinoid lipid signaling molecules and amino acids. Journal of Neuroinflammation. 17: 345. PMID 33208151 DOI: 10.1186/s12974-020-01971-6 |
0.812 |
|
| 2020 |
Fitting S, McRae M, Hauser KF. Opioid and neuroHIV Comorbidity - Current and Future Perspectives. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 32876803 DOI: 10.1007/S11481-020-09941-8 |
0.735 |
|
| 2019 |
Jacobs IR, Xu C, Hermes DJ, League AF, Xu C, Nath B, Jiang W, Niphakis MJ, Cravatt BF, Mackie K, Mukhopadhyay S, Lichtman AH, Ignatowska-Jankowska BM, Fitting S. Inhibitory Control Deficits Associated with Upregulation of CBR in the HIV-1 Tat Transgenic Mouse Model of Hand. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 31372820 DOI: 10.1007/S11481-019-09867-W |
0.799 |
|
| 2018 |
Hermes DJ, Xu C, Poklis JL, Niphakis MJ, Cravatt BF, Mackie K, Lichtman AH, Ignatowska-Jankowska BM, Fitting S. Neuroprotective effects of fatty acid amide hydrolase catabolic enzyme inhibition in a HIV-1 Tat model of neuroAIDS. Neuropharmacology. PMID 30114402 DOI: 10.1016/J.Neuropharm.2018.08.013 |
0.516 |
|
| 2017 |
Fitting S, McLaurin KA, Booze RM, Mactutus CF. Dose-dependent neurocognitive deficits following postnatal day 10 HIV-1 viral protein exposure: Relationship to hippocampal anatomy parameters. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. PMID 29111178 DOI: 10.1016/J.Ijdevneu.2017.10.009 |
0.834 |
|
| 2017 |
Xu C, Hermes DJ, Nwanguma B, Jacobs IR, Mackie K, Mukhopadhyay S, Lichtman AH, Ignatowska-Jankowska B, Fitting S. Endocannabinoids exert CB1 receptor-mediated neuroprotective effects in models of neuronal damage induced by HIV-1 Tat protein. Molecular and Cellular Neurosciences. PMID 28733129 DOI: 10.1016/J.Mcn.2017.07.003 |
0.555 |
|
| 2016 |
Xu C, Fitting S. Inhibition of GABAergic Neurotransmission by HIV-1 Tat and Opioid Treatment in the Striatum Involves μ-Opioid Receptors. Frontiers in Neuroscience. 10: 497. PMID 27877102 DOI: 10.3389/Fnins.2016.00497 |
0.54 |
|
| 2016 |
Guedia J, Brun P, Bhave S, Fitting S, Kang M, Dewey WL, Hauser KF, Akbarali HI. HIV-1 Tat exacerbates lipopolysaccharide-induced cytokine release via TLR4 signaling in the enteric nervous system. Scientific Reports. 6: 31203. PMID 27491828 DOI: 10.1038/Srep31203 |
0.678 |
|
| 2016 |
Marks WD, Paris JJ, Schier CJ, Denton MD, Fitting S, McQuiston AR, Knapp PE, Hauser KF. HIV-1 Tat causes cognitive deficits and selective loss of parvalbumin, somatostatin, and neuronal nitric oxide synthase expressing hippocampal CA1 interneuron subpopulations. Journal of Neurovirology. PMID 27178324 DOI: 10.1007/S13365-016-0447-2 |
0.806 |
|
| 2016 |
Xu C, Hermes DJ, Mackie K, Lichtman AH, Ignatowska-Jankowska BM, Fitting S. Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic Neurotransmission in Prefrontal Cortex Slices. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 26993829 DOI: 10.1007/S11481-016-9664-Y |
0.56 |
|
| 2015 |
Fitting S, Stevens DL, Khan FA, Scoggins KL, Enga RM, Beardsley PM, Knapp PE, Dewey WL, Hauser KF. Morphine tolerance and physical dependence are altered in conditional HIV-1 Tat transgenic mice. The Journal of Pharmacology and Experimental Therapeutics. PMID 26542403 DOI: 10.1124/Jpet.115.226407 |
0.715 |
|
| 2015 |
Zou S, Fuss B, Fitting S, Hahn YK, Hauser KF, Knapp PE. Oligodendrocytes Are Targets of HIV-1 Tat: NMDA and AMPA Receptor-Mediated Effects on Survival and Development. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 11384-98. PMID 26269645 DOI: 10.1523/Jneurosci.4740-14.2015 |
0.707 |
|
| 2015 |
Fitting S, Ngwainmbi J, Kang M, Khan FA, Stevens DL, Dewey WL, Knapp PE, Hauser KF, Akbarali HI. Sensitization of enteric neurons to morphine by HIV-1 Tat protein. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 27: 468-80. PMID 25703354 DOI: 10.1111/Nmo.12514 |
0.746 |
|
| 2015 |
Fitting S, Booze RM, Mactutus CF. HIV-1 proteins, Tat and gp120, target the developing dopamine system. Current Hiv Research. 13: 21-42. PMID 25613135 DOI: 10.2174/1570162X13666150121110731 |
0.786 |
|
| 2015 |
Ellis K, Marlin JW, Taylor TA, Fitting S, Hauser KF, Rice G, McRae M. The effects of human immunodeficiency virus infection on the expression of the drug efflux proteins P-glycoprotein and breast cancer resistance protein in a human intestine model. The Journal of Pharmacy and Pharmacology. 67: 178-88. PMID 25557407 DOI: 10.1111/Jphp.12329 |
0.689 |
|
| 2015 |
Watanabe H, Fitting S, Hussain MZ, Kononenko O, Iatsyshyna A, Yoshitake T, Kehr J, Alkass K, Druid H, Wadensten H, Andren PE, Nylander I, Wedell DH, Krishtal O, Hauser KF, et al. Asymmetry of the endogenous opioid system in the human anterior cingulate: a putative molecular basis for lateralization of emotions and pain. Cerebral Cortex (New York, N.Y. : 1991). 25: 97-108. PMID 23960211 DOI: 10.1093/Cercor/Bht204 |
0.569 |
|
| 2014 |
Fitting S, Zou S, El-Hage N, Suzuki M, Paris JJ, Schier CJ, Rodríguez JW, Rodriguez M, Knapp PE, Hauser KF. Opiate addiction therapies and HIV-1 Tat: interactive effects on glial [Ca²⁺]i, oxyradical and neuroinflammatory chemokine production and correlative neurotoxicity. Current Hiv Research. 12: 424-34. PMID 25760046 DOI: 10.2174/1570162X1206150311161147 |
0.798 |
|
| 2014 |
Ngwainmbi J, De DD, Smith TH, El-Hage N, Fitting S, Kang M, Dewey WL, Hauser KF, Akbarali HI. Effects of HIV-1 Tat on enteric neuropathogenesis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 14243-51. PMID 25339738 DOI: 10.1523/Jneurosci.2283-14.2014 |
0.809 |
|
| 2014 |
Moran LM, Fitting S, Booze RM, Webb KM, Mactutus CF. Neonatal intrahippocampal HIV-1 protein Tat(1-86) injection: neurobehavioral alterations in the absence of increased inflammatory cytokine activation. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 38: 195-203. PMID 25285887 DOI: 10.1016/J.Ijdevneu.2014.09.004 |
0.848 |
|
| 2014 |
Fitting S, Knapp PE, Zou S, Marks WD, Bowers MS, Akbarali HI, Hauser KF. Interactive HIV-1 Tat and morphine-induced synaptodendritic injury is triggered through focal disruptions in Na⺠influx, mitochondrial instability, and Ca²⺠overload. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 12850-64. PMID 25232120 DOI: 10.1523/JNEUROSCI.5351-13.2014 |
0.789 |
|
| 2014 |
Fitting S, Zou S, El-Hage N, Suzuki M, Paris JJ, Schier CJ, Rodriguez JW, Rodriguez M, Knapp PE, Hauser KF. Opiate addiction therapies and HIV-1 tat: Interactive effects on glial [Ca2+]i, oxyradical and neuroinflammatory chemokine production and correlative neurotoxicity Current Hiv Research. 12: 424-434. |
0.82 |
|
| 2013 |
Fitting S, Ignatowska-Jankowska BM, Bull C, Skoff RP, Lichtman AH, Wise LE, Fox MA, Su J, Medina AE, Krahe TE, Knapp PE, Guido W, Hauser KF. Synaptic dysfunction in the hippocampus accompanies learning and memory deficits in human immunodeficiency virus type-1 Tat transgenic mice. Biological Psychiatry. 73: 443-53. PMID 23218253 DOI: 10.1016/J.Biopsych.2012.09.026 |
0.673 |
|
| 2013 |
Yakovleva T, Fitting S, Scheff SW, Hauser KF, Bakalkin G. Lateralized response in dynorphin A peptide levels after traumatic brain injury Journal of the Neurological Sciences. 333. DOI: 10.1016/J.Jns.2013.07.1984 |
0.51 |
|
| 2012 |
Fitting S, Scoggins KL, Xu R, Dever SM, Knapp PE, Dewey WL, Hauser KF. Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice. European Journal of Pharmacology. 689: 96-103. PMID 22659585 DOI: 10.1016/J.Ejphar.2012.05.029 |
0.85 |
|
| 2012 |
Hauser KF, Fitting S, Dever SM, Podhaizer EM, Knapp PE. Opiate drug use and the pathophysiology of neuroAIDS. Current Hiv Research. 10: 435-52. PMID 22591368 DOI: 10.2174/157016212802138779 |
0.841 |
|
| 2012 |
Dever SM, Xu R, Fitting S, Knapp PE, Hauser KF. Differential expression and HIV-1 regulation of μ-opioid receptor splice variants across human central nervous system cell types. Journal of Neurovirology. 18: 181-90. PMID 22528479 DOI: 10.1007/S13365-012-0096-Z |
0.819 |
|
| 2012 |
Hussain ZM, Fitting S, Watanabe H, Usynin I, Yakovleva T, Knapp PE, Scheff SW, Hauser KF, Bakalkin G. Lateralized response of dynorphin a peptide levels after traumatic brain injury. Journal of Neurotrauma. 29: 1785-93. PMID 22468884 DOI: 10.1089/Neu.2011.2286 |
0.556 |
|
| 2012 |
Podhaizer EM, Zou S, Fitting S, Samano KL, El-Hage N, Knapp PE, Hauser KF. Morphine and gp120 toxic interactions in striatal neurons are dependent on HIV-1 strain. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 7: 877-91. PMID 22101471 DOI: 10.1007/S11481-011-9326-Z |
0.786 |
|
| 2011 |
Zou S, Fitting S, Hahn YK, Welch SP, El-Hage N, Hauser KF, Knapp PE. Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at μ-opioid receptor-expressing glia. Brain : a Journal of Neurology. 134: 3616-31. PMID 22102648 DOI: 10.1093/Brain/Awr281 |
0.778 |
|
| 2011 |
El-Hage N, Dever SM, Fitting S, Ahmed T, Hauser KF. HIV-1 coinfection and morphine coexposure severely dysregulate hepatitis C virus-induced hepatic proinflammatory cytokine release and free radical production: increased pathogenesis coincides with uncoordinated host defenses. Journal of Virology. 85: 11601-14. PMID 21900165 DOI: 10.1128/Jvi.05239-11 |
0.825 |
|
| 2010 |
Fitting S, Xu R, Bull C, Buch SK, El-Hage N, Nath A, Knapp PE, Hauser KF. Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons. The American Journal of Pathology. 177: 1397-410. PMID 20651230 DOI: 10.2353/Ajpath.2010.090945 |
0.834 |
|
| 2010 |
Hahn YK, Vo P, Fitting S, Block ML, Hauser KF, Knapp PE. beta-Chemokine production by neural and glial progenitor cells is enhanced by HIV-1 Tat: effects on microglial migration. Journal of Neurochemistry. 114: 97-109. PMID 20403075 DOI: 10.1111/J.1471-4159.2010.06744.X |
0.712 |
|
| 2010 |
Fitting S, Zou S, Chen W, Vo P, Hauser KF, Knapp PE. Regional heterogeneity and diversity in cytokine and chemokine production by astroglia: differential responses to HIV-1 Tat, gp120, and morphine revealed by multiplex analysis. Journal of Proteome Research. 9: 1795-804. PMID 20121167 DOI: 10.1021/Pr900926N |
0.737 |
|
| 2010 |
Fitting S, Booze RM, Hasselrot U, Mactutus CF. Dose-dependent long-term effects of Tat in the rat hippocampal formation: a design-based stereological study. Hippocampus. 20: 469-80. PMID 19489004 DOI: 10.1002/Hipo.20648 |
0.783 |
|
| 2008 |
Fitting S, Booze RM, Mactutus CF. Neonatal intrahippocampal injection of the HIV-1 proteins gp120 and Tat: differential effects on behavior and the relationship to stereological hippocampal measures. Brain Research. 1232: 139-54. PMID 18674522 DOI: 10.1016/J.Brainres.2008.07.032 |
0.783 |
|
| 2008 |
Harrod SB, Mactutus CF, Fitting S, Hasselrot U, Booze RM. Intra-accumbal Tat1-72 alters acute and sensitized responses to cocaine. Pharmacology, Biochemistry, and Behavior. 90: 723-9. PMID 18582493 DOI: 10.1016/J.Pbb.2008.05.020 |
0.676 |
|
| 2008 |
Fitting S, Booze RM, Gilbert CA, Mactutus CF. Effects of chronic adult dietary restriction on spatial learning in the aged F344 x BN hybrid F1 rat. Physiology & Behavior. 93: 560-9. PMID 18035382 DOI: 10.1016/J.Physbeh.2007.10.017 |
0.668 |
|
| 2008 |
Fitting S, Booze RM, Hasselrot U, Mactutus CF. Differential long-term neurotoxicity of HIV-1 proteins in the rat hippocampal formation: a design-based stereological study. Hippocampus. 18: 135-47. PMID 17924522 DOI: 10.1002/Hipo.20376 |
0.765 |
|
| 2007 |
Fitting S, Booze RM, Mactutus CF. Neonatal intrahippocampal gp120 injection: an examination early in development. Neurotoxicology. 28: 101-7. PMID 16973215 DOI: 10.1016/J.Neuro.2006.07.014 |
0.736 |
|
| 2007 |
Fitting S, Booze R, Mactutus C. Effects of the HIV-1 proteins, Tat and gp120, on spatial learning and memory Neurotoxicology and Teratology. 29: 409. DOI: 10.1016/J.Ntt.2007.03.045 |
0.75 |
|
| 2007 |
Hord L, Webb K, Fitting S, Booze R, Strupp B, Mactutus C. Prenatal intravenous (IV) cocaine: Differential long-term effects on pre-attentive processes in females and males Neurotoxicology and Teratology. 29: 403. DOI: 10.1016/J.Ntt.2007.03.029 |
0.733 |
|
| 2006 |
Fitting S, Booze RM, Hasselrot U, Mactutus CF. Intrahippocampal injections of Tat: effects on prepulse inhibition of the auditory startle response in adult male rats. Pharmacology, Biochemistry, and Behavior. 84: 189-96. PMID 16790267 DOI: 10.1016/J.Pbb.2006.04.014 |
0.714 |
|
| 2006 |
Fitting S, Booze RM, Mactutus CF. Neonatal intrahippocampal glycoprotein 120 injection: the role of dopaminergic alterations in prepulse inhibition in adult rats. The Journal of Pharmacology and Experimental Therapeutics. 318: 1352-8. PMID 16785316 DOI: 10.1124/Jpet.106.105742 |
0.699 |
|
| 2006 |
Fitting S, Booze RM, Mactutus CF. Neonatal hippocampal Tat injections: developmental effects on prepulse inhibition (PPI) of the auditory startle response. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 24: 275-83. PMID 16530999 DOI: 10.1016/J.Ijdevneu.2006.02.001 |
0.744 |
|
| Show low-probability matches. |